GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roivant Sciences Ltd (STU:87S) » Definitions » General and Admin. Expense

Roivant Sciences (STU:87S) General and Admin. Expense : €501.7 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Roivant Sciences General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Roivant Sciences's General and Admin. Expense for the three months ended in Sep. 2024 was €182.8 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2024 was €501.7 Mil.

Roivant Sciences General and Admin. Expense Historical Data

The historical data trend for Roivant Sciences's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roivant Sciences General and Admin. Expense Chart

Roivant Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24
General and Admin. Expense
218.30 703.73 560.87 -

Roivant Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.00 180.91 - 137.97 182.80

Roivant Sciences General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €501.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roivant Sciences General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Roivant Sciences's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Roivant Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roivant Sciences Ltd (STU:87S) » Definitions » General and Admin. Expense
Comparable Companies
EXEL IONS KRTX APLS JAZZ ABCZF ASND IMVT HALO PCVX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
ROIV:USA 87S:Germany
Address
50 Broadway, 7th Floor, London, GBR, SW1H 0BD
Website
https://www.roivant.com
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Roivant Sciences Headlines

No Headlines